LMAT · CIK 0001158895 · operating
# LeMaitre Vascular, Inc.
LeMaitre Vascular develops, manufactures, and markets medical devices and biological implants for vascular surgery and cardiovascular procedures. The company's product portfolio spans allografts, which are cryopreserved human tissue grafts used in vascular and cardiac reconstruction; catheters for embolectomy, thrombectomy, occlusion, and perfusion applications; and a range of biologic patches derived from bovine, porcine, and biosynthetic materials. Additionally, the company manufactures vascular grafts including expanded polytetrafluoroethylene options, closure systems using titanium clips, carotid shunts, and instruments for vein procedures such as valvulotomes and phlebectomy systems. The company also provides human cadaver tissue cryopreservation services.
LeMaitre Vascular distributes its products globally across the Americas, Europe, the Middle East, Africa, and Asia Pacific through a combination of direct sales personnel and third-party distributors. The company was incorporated in 1983 and is based in Burlington, Massachusetts.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2025 | $2.52 | $2.55 | +30.6% | |
| 2024 | $1.93 | $1.96 | +407.9% | |
| 2023 | $0.38 | $0.38 | +52.0% | |
| 2022 | $0.25 | $0.26 | -10.7% | |
| 2021 | $0.28 | $0.28 | -17.6% | |
| 2020 | $0.34 | $0.35 | +47.8% | |
| 2019 | $0.23 | $0.23 | -23.3% | |
| 2018 | $0.30 | $0.31 | +42.9% | |
| 2017 | $0.21 | $0.22 | +61.5% | |
| 2016 | $0.13 | $0.14 | +0.0% | |
| 2015 | $0.13 | $0.14 | +18.2% | |
| 2014 | $0.11 | $0.11 | +120.0% | |
| 2013 | $0.05 | $0.05 | +25.0% | |
| 2012 | $0.04 | $0.05 | -69.2% | |
| 2011 | $0.13 | $0.14 | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2025-12-31 | 2026-02-26 | 0001193125-26-073360 | SEC ↗ |
| 2024-12-31 | 2025-02-28 | 0001437749-25-005637 | SEC ↗ |
| 2023-12-31 | 2024-02-29 | 0001437749-24-006037 | SEC ↗ |
| 2022-12-31 | 2023-03-01 | 0001437749-23-005056 | SEC ↗ |
| 2021-12-31 | 2022-02-28 | 0001437749-22-004662 | SEC ↗ |
| 2020-12-31 | 2021-03-12 | 0001437749-21-005956 | SEC ↗ |
| 2019-12-31 | 2020-03-12 | 0001437749-20-004836 | SEC ↗ |
| 2018-12-31 | 2019-03-11 | 0001437749-19-004574 | SEC ↗ |
| 2017-12-31 | 2018-03-09 | 0001193125-18-076905 | SEC ↗ |
| 2016-12-31 | 2017-03-09 | 0001193125-17-074936 | SEC ↗ |
| 2015-12-31 | 2016-03-10 | 0001193125-16-499592 | SEC ↗ |